Uptitrating mycophenolate mofetil therapy in a patient with lupus cerebritis doesn’t increase risk of infection compared to cyclophosphamide

Abstract

A clinical decision report using: Appel GB, Contreras G, Dooley MA, et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol. 2009;20(5):1103-1112. https://doi.org/10.1681/ASN.2008101028 for a patient with neuropsychiatric lupus.